thymoquinone has been researched along with scopolamine hydrobromide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Ali, SA; Meitei, KV | 1 |
Acun, AD; Danışman, B; Kantar, D | 1 |
Abdallah, MS; Abo Mansour, HE; Alhaddad, AA; El-Berri, EI; Elberri, AI; Ghoneim, ME; Mosalam, EM; Salem, MA; Samman, WA | 1 |
3 other study(ies) available for thymoquinone and scopolamine hydrobromide
Article | Year |
---|---|
Nigella sativa seed extract and its bioactive compound thymoquinone: the new melanogens causing hyperpigmentation in the wall lizard melanophores.
Topics: Animals; Atropine; Benzoquinones; Cholinesterase Inhibitors; Dermatologic Agents; Hyperpigmentation; Hypopigmentation; Lizards; Melanins; Melanophores; Neostigmine; Nigella sativa; Plant Extracts; Scopolamine; Seeds; Skin; Sodium Chloride | 2011 |
Effects of thymoquinone on scopolamine-induced spatial and echoic memory changes through regulation of lipid peroxidation and cholinergic impairment.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Benzoquinones; Cholinergic Agents; Hippocampus; Lipid Peroxidation; Maze Learning; Memory Disorders; Oxidative Stress; Rats; Rats, Wistar; Scopolamine; Thiobarbituric Acid Reactive Substances | 2022 |
The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Mice; Neuroprotective Agents; PPAR gamma; Scopolamine | 2023 |